Skip to main content
. Author manuscript; available in PMC: 2009 Jul 22.
Published in final edited form as: Am J Cardiol. 2009 Mar 13;103(9):1269–1274. doi: 10.1016/j.amjcard.2009.01.026

Table 1.

Baseline characteristics according to quartiles of systemic myeloperoxidase (MPO)

Characteristics MPC Quartiles (pmol/L)
<170 (n = 950) 170–261 (n = 938) 262–432 (n = 949) >432 (n = 896) p Value (trend)
Age (yrs) 75 ± 5 75 ± 5 75 ± 5 74 ± 5 0.068
Men 364 (38%) 342 (37%) 350 (37%) 387 (43%) 0.041
African Americans 142 (15%) 149 (16%) 167 (17%) 166 (19%) 0.023
Systolic blood pressure (mm Hg) 138 (21) 136 (22) 137 (21) 134 (20) 0.001
Diastolic blood pressure (mm Hg) 71 (12) 72 (11) 72 (10) 71 (11) 0.742
Antihypertensive therapy 421 (44%) 410 (44%) 437 (46%) 416 (46%) 0.252
Smoker (current) 79 (9%) 84 (9%) 93 (10%) 112 (13%) 0.003
LDL cholesterol (mg/dl) 128 ± 33 129 ± 33 127 ± 34 126 ± 33 0.124
High-density lipoprotein cholesterol (mg/dl) 53 ± 14 55 ± 15 55 ± 15 54 ± 14 0.077
Diabetes mellitus 148 (16%) 135 (14%) 111 (12%) 117 (13%) 0.039
Subclinical cardiovascular diseases 609 (66%) 615 (67%) 625 (68%) 574 (65%) 0.993
C-Reactive protein (mg/L) 2.03 (0.99–4.03) 2.18 (1.12–5.03) 2.54 (1.19–6.09) 3.93 (1.65–8.56) <0.001
Cystatin C (mg/L) 1.06 ± 0.26 1.07 ± 0.26 1.10 ± 0.28 1.10 ± 0.32 <0.001

Values expressed as mean ± SD, number (percent), or median (interquartile range).